JPT Peptide Technologies GMBH

Berlin, BE

UEI
MXL9VASUBCN8
CAGE
C8859
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
Hermann-Dorner-Allee 23, 12489 Berlin, Germany
Website
jpt.com
Founded
2004
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 $164,578

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
Dana-Farber Cancer Institute, Inc. JPT shall deliver reference peptides that are critical components of the LC-DIAMS method to be used in Aim For the production of the peptides, JPT's… R01CA265928 $21,600
Dana-Farber Cancer Institute, Inc. JPT shall deliver reference peptides that are critical components of the LC-DIAMS method to be used in Aim For the production of the peptides, JPT's… R01CA265928 $44,820

Similar vendors

About the company

JPT Peptide Technologies GMBH is a leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. Through federal contract awards, JPT has provided peptide mixtures, reagents, assay kits, laboratory testing services, drugs and biologicals to the Department of Health and Human Services National Institutes of Health National Cancer Institute and National Institute of Allergy and Infectious Diseases as well as the Department of Agriculture Agricultural Research Service. The contract awards have supported research related to cancer, COVID-19, allergies, and infectious diseases.

JPT has received federal contract awards totaling over $250,000 over recent years. The awards have included firm fixed price purchase orders for goods and services such as custom peptide synthesis, peptide library preparation, assay kit provision, and testing services. JPT has provided deliverables directly to federal agencies as a prime contractor, with no set aside provisions on the awards.

As a subcontractor under a National Institutes of Health grant to the Dana-Farber Cancer Institute, JPT is delivering critical reference peptides and overseeing development of standard operating procedures related to liquid chromatography mass spectrometry workflows for clinical proteomics. The project aims to validate peptide synthesis methods and develop commercial peptide kits to enable normalization experiments.

Quick answers

Is JPT Peptide Technologies GMBH registered in SAM.gov?

Yes. JPT Peptide Technologies GMBH's SAM.gov registration is active through March 18, 2027.

What is JPT Peptide Technologies GMBH's CAGE code?

JPT Peptide Technologies GMBH's CAGE code is C8859, and its Unique Entity ID (UEI) is MXL9VASUBCN8.

How much has JPT Peptide Technologies GMBH received in federal contracts?

Federal contracts obligated $164,578 to JPT Peptide Technologies GMBH in fiscal years 2023 through 2027.

What is JPT Peptide Technologies GMBH's most recent federal award?

JPT Peptide Technologies GMBH's most recent federal contract award is Custom pepmix: HPV16 and rabies, pooling service, aliquotation service, bacterial endotoxin testing (75N91023P00884), from National Cancer Institute (NIH), on September 22, 2023.

On GovTribe

See JPT Peptide Technologies GMBH's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe